Ironwood CFO Gregory Martini resigns; Ronald Silver named interim CFO

IRONWOOD PHARMACEUTICALS INC

Gregory Martini resigns as SVP, CFO effective May 15, 2026, not due to any disagreement with the company on financial reporting.
Ronald Silver, SVP Corporate Controller and CAO, appointed interim CFO and principal financial officer effective May 15, 2026.
Silver joined Ironwood in June 2018; served as Corporate Controller and CAO since January 2025.
Silver is a CPA with prior roles at Eze Software Group and RSM, LLP, and holds a B.S. from U. Maryland and MBA from Georgetown.
No family relationships with directors/executives; no transactions requiring disclosure under Reg S-K Item 404(a).

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Ronald Silver

interim chief financial officer and principal financial officer

IRWD · IRONWOOD PHARMACEUTICALS INC

Effective: 2026-05-15
Filed: May 13, 2026, 8:00 AM ET

Effective May 15, 2026, Ronald Silver, age 44, the Company’s Senior Vice President, Corporate Controller and Chief Accounting Officer, will also serve as the Company’s interim chief financial officer and principal financial officer.

Departed (interim)

Gregory Martini

Senior Vice President, Chief Financial Officer

IRWD · IRONWOOD PHARMACEUTICALS INC

Effective: 2026-05-15
Successor: Ronald Silver
Filed: May 13, 2026, 8:00 AM ET

On May 8, 2026, Gregory Martini notified Ironwood Pharmaceuticals, Inc. (the “Company”) that he is resigning from his position as Senior Vice President, Chief Financial Officer, effective May 15, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ronald Silver was appointed as interim chief financial officer and principal financial officer at IRONWOOD PHARMACEUTICALS INC.

Action: will also serve
Role: interim chief financial officer and principal financial officer

Exact text from the filing

Effective May 15, 2026, Ronald Silver, age 44, the Company’s Senior Vice President, Corporate Controller and Chief Accounting Officer, will also serve as the Company’s interim chief financial officer and principal financial officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Gregory Martini departed as Senior Vice President, Chief Financial Officer at IRONWOOD PHARMACEUTICALS INC.

Action: resigning
Role: Senior Vice President, Chief Financial Officer

Exact text from the filing

On May 8, 2026, Gregory Martini notified Ironwood Pharmaceuticals, Inc. (the “Company”) that he is resigning from his position as Senior Vice President, Chief Financial Officer, effective May 15, 2026.

View on SEC.gov

IRONWOOD PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-26-059814

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.